KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Inventory: 2017-2024

Historic Inventory for Dynavax Technologies (DVAX) over the last 8 years, with Dec 2024 value amounting to $70.1 million.

  • Dynavax Technologies' Inventory rose 17.44% to $73.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.3 million, marking a year-over-year increase of 17.44%. This contributed to the annual value of $70.1 million for FY2024, which is 31.46% up from last year.
  • According to the latest figures from FY2024, Dynavax Technologies' Inventory is $70.1 million, which was up 31.46% from $53.3 million recorded in FY2023.
  • Dynavax Technologies' 5-year Inventory high stood at $70.1 million for FY2024, and its period low was $53.3 million during FY2023.
  • Moreover, its 3-year median value for Inventory was $59.4 million (2022), whereas its average is $60.9 million.
  • Its Inventory has fluctuated over the past 5 years, first soared by 54.09% in 2020, then declined by 10.36% in 2023.
  • Over the past 5 years, Dynavax Technologies' Inventory (Yearly) stood at $63.7 million in 2020, then fell by 3.70% to $61.3 million in 2021, then fell by 3.08% to $59.4 million in 2022, then dropped by 10.36% to $53.3 million in 2023, then skyrocketed by 31.46% to $70.1 million in 2024.